# Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

> **NCT07432360** · — · RECRUITING · sponsor: **Virdx, Inc.** · enrollment: 300 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07432360
- **Lead sponsor:** Virdx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07432360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07432360, "Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07432360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*